Seeking Alpha

FDA approves the first migraine prevention device

  • FDA approves the first transcutaneous electrical nerve stimulation (TENS) device, made by the Belgian firm STX-Med, for the prevention of migraine headaches.
  • The product, called Cefaly, is battery operated and resembles a plastic headband worn across the forehead.
  • Cefaly is available by prescription to patients aged 18 years and older. It should be used only once per day for no more than 20 minutes.
  • Other FDA-approved products, such as TEVA's (TEVA) Zecuity, treat migraine symptoms.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs